^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    BBT-207

    i
    Other names: BBT-207
    Associations

    News

    Trials
    Company:
    Bridge Biotherap
    Drug class:
    EGFR inhibitor
    Related drugs:
    Associations

    News

    Trials
    over1year
    First-in-Human Study of BBT-207 in Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation After Treatment With EGFR TKI (clinicaltrials.gov)
    P1/2, N=92, Not yet recruiting, Bridge Biotherapeutics, Inc.
    New P1/2 trial • Metastases
    |
    EGFR mutation • EGFR L858R • EGFR exon 19 deletion • EGFR C797S
    |
    BBT-207